-
1
-
-
85047693638
-
Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones
-
Norris AW, Chen L, Fisher SJ, et al. Muscle-specific PPARγ- deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest. 2003;112:608-618.
-
(2003)
J Clin Invest
, vol.112
, pp. 608-618
-
-
Norris, A.W.1
Chen, L.2
Fisher, S.J.3
-
2
-
-
0035851187
-
PPAR gamma: A nuclear regulator of metabolism, differentiation and cell growth
-
Rosen ED, Spiegelman BM. PPAR gamma: a nuclear regulator of metabolism, differentiation and cell growth. J Biol Chem. 2001;37731-37743.
-
(2001)
J Biol Chem
, pp. 37731-37743
-
-
Rosen, E.D.1
Spiegelman, B.M.2
-
3
-
-
0031197036
-
Peroxisome proliferator-activated receptor agonists
-
Wilson TM, Wahli W. Peroxisome proliferator-activated receptor agonists. Curr Opin Chem Biol. 1997;1:235-241.
-
(1997)
Curr Opin Chem Biol
, vol.1
, pp. 235-241
-
-
Wilson, T.M.1
Wahli, W.2
-
4
-
-
0024463719
-
A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding
-
Kraegen EW, James DE, Jenkins AB, Chisholm DJ, Storlien LH. A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding. Metabolism. 1989;38:1089-1093.
-
(1989)
Metabolism
, vol.38
, pp. 1089-1093
-
-
Kraegen, E.W.1
James, D.E.2
Jenkins, A.B.3
Chisholm, D.J.4
Storlien, L.H.5
-
5
-
-
0034033388
-
Mechanism of troglitazone action on type 2 diabetes
-
Peterson KF, Krssak M, Inzucchi S, Cline GW, Dufour S, Shulman GL. Mechanism of troglitazone action on type 2 diabetes. Diabetes. 2000;49:827-831.
-
(2000)
Diabetes
, vol.49
, pp. 827-831
-
-
Peterson, K.F.1
Krssak, M.2
Inzucchi, S.3
Cline, G.W.4
Dufour, S.5
Shulman, G.L.6
-
6
-
-
0031712627
-
Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells
-
Arakawa K, Ishihara T, Aoto M, et al. Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells. Br J Pharmacol. 1998;125:429-436.
-
(1998)
Br J Pharmacol
, vol.125
, pp. 429-436
-
-
Arakawa, K.1
Ishihara, T.2
Aoto, M.3
-
7
-
-
0036205326
-
Conditional disruption of the peroxisome proliferator-activated receptor γ in mice results in lowered expression of ABCA1, ABCG1 and apoE in macrophages and reduced cholesterol efflux
-
Akiyama TE, Sakai S, Lambert G, et al. Conditional disruption of the peroxisome proliferator-activated receptor γ in mice results in lowered expression of ABCA1, ABCG1 and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol. 2002;22:2607-2619.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 2607-2619
-
-
Akiyama, T.E.1
Sakai, S.2
Lambert, G.3
-
8
-
-
0032189782
-
Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
-
Ristow M, Muller-Wieland D, Pfeiffer A, Kone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med. 1998;339:953-959.
-
(1998)
N Engl J Med
, vol.339
, pp. 953-959
-
-
Ristow, M.1
Muller-Wieland, D.2
Pfeiffer, A.3
Kone, W.4
Kahn, C.R.5
-
9
-
-
7844240131
-
Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPAR gamma agonist) action
-
Zierath JR, Ryder JW, Doebber T, et al. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPAR gamma agonist) action. Endocrinology. 1998;139:5034-5041.
-
(1998)
Endocrinology
, vol.139
, pp. 5034-5041
-
-
Zierath, J.R.1
Ryder, J.W.2
Doebber, T.3
-
10
-
-
0029892126
-
An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues
-
Berger J, Biswas C, Hayes N, Ventre J, Wu M, Doebber TW. An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues. Endocrinology. 1996;137:1984-1990.
-
(1996)
Endocrinology
, vol.137
, pp. 1984-1990
-
-
Berger, J.1
Biswas, C.2
Hayes, N.3
Ventre, J.4
Wu, M.5
Doebber, T.W.6
-
11
-
-
0036326005
-
Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists
-
Jiang G, Dallas-Yang Q, Li Z, et al. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists. Diabetes. 2002;51:2412-2419.
-
(2002)
Diabetes
, vol.51
, pp. 2412-2419
-
-
Jiang, G.1
Dallas-Yang, Q.2
Li, Z.3
-
12
-
-
0034663140
-
Efficacy and safety of thiazolidinedione treatment of lipodystrophy syndromes
-
Arioglu E, Duncan-Morin J, Sebring N, et al. Efficacy and safety of thiazolidinedione treatment of lipodystrophy syndromes. Ann Intern Med. 2000;133:263-274.
-
(2000)
Ann Intern Med
, vol.133
, pp. 263-274
-
-
Arioglu, E.1
Duncan-Morin, J.2
Sebring, N.3
-
13
-
-
0031441286
-
Troglitazone action is independent of adipose tissue
-
Burant CF, Sreenan S, Hirano K, et al. Troglitazone action is independent of adipose tissue. J Clin Invest. 1997;100:2900-2908.
-
(1997)
J Clin Invest
, vol.100
, pp. 2900-2908
-
-
Burant, C.F.1
Sreenan, S.2
Hirano, K.3
-
14
-
-
0141446024
-
Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance and regulation of body fat mass
-
Gavrilova O, Haluzik M, Matsusue K, et al. Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance and regulation of body fat mass. J Biol Chem. 2003;278:34268-34276.
-
(2003)
J Biol Chem
, vol.278
, pp. 34268-34276
-
-
Gavrilova, O.1
Haluzik, M.2
Matsusue, K.3
-
15
-
-
0032532753
-
Life without white fat: A transgenic mouse
-
Moitra J, Mason MM, Olive M, et al. Life without white fat: a transgenic mouse. Genes Dev. 1998;12:3168-3181.
-
(1998)
Genes Dev
, vol.12
, pp. 3168-3181
-
-
Moitra, J.1
Mason, M.M.2
Olive, M.3
|